In this video series, we invite you to sit down with influential ophthalmologists and key members of their surgical staff as they discuss why PROLENSA® is their post-cataract surgery NSAID of choice and how they’ve implemented successful treatment protocols in their practices to ensure their patients receive PROLENSA® as prescribed.
Please see Indication and Important Safety Information below
Download and share these resources with your practice and patients.
PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Click here for full prescribing information on PROLENSA®
PROLENSA is a trademark of Bausch & Lomb Incorporated or its affiliates. Any other products/brand names are trademarks of the respective owners.